Ayse Cirakoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayse Cirakoglu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Yelda Tarkan Argüden
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Trkiye
3 shared publications - Ayhan Devi̇ren
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
2 shared publications - Rahiye Dilhan Kuru
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
2 shared publications - Şükriye Yilmaz
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
2 shared publications - Aykut Ferhat Celik
Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty Hospital , Fatih/Istanbul
1 shared publication - Ayse Salihoglu
Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
1 shared publication
Latest Publications
- 28 July 2023
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 15 (2) , 95-101
Conventional and molecular cytogenetic analyses in Behçet’s syndrome patients with gastrointestinal involvement
- 28 July 2023
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 15 (2) , 95-101
Conventional and molecular cytogenetic analyses in Behçet’s syndrome patients with gastrointestinal involvement
- 4 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 20 (5) , 2959-2969
Gene Teams are on the Field: Evaluation of Variants in Gene-Networks Using High Dimensional Modelling
In medical genetics, each genetic variant is evaluated as an independent entity regarding its clinical importance. However, in most complex diseases, variant combinations in specific gene networks, rather than the presence of a particular single variant, predominates. In the case of complex diseases, disease status can be evaluated by considering the success level of a team of specific variants. We propose a high dimensional modelling based method to analyse all the variants in a gene network together, which we name “Computational Gene Network Analysis” (CoGNA).To evaluate our method, we selected two gene networks, mTOR and TGF- $\beta$ . For each pathway, we generated 400 control and 400 patient group samples. mTOR and TGF- $\beta$ pathways contain 31 and 93 genes of varying sizes, respectively. We produced Chaos Game Representation images for each gene sequence to obtain 2-D binary patterns. These patterns were arranged in succession, and a 3-D tensor structure was achieved for each gene network. Features for each data sample were acquired by exploiting Enhanced Multivariance Products Representation to 3-D data. Features were split as training and testing vectors. Training vectors were employed to train a Support Vector Machines classification model. We achieved more than $96\%$ and $99\%$ classification accuracies for mTOR and TGF- $\beta$ networks, respectively, using a limited amount of training samples.
- 4 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Vol. 20 (5) , 2959-2969
Gene Teams are on the Field: Evaluation of Variants in Gene-Networks Using High Dimensional Modelling
In medical genetics, each genetic variant is evaluated as an independent entity regarding its clinical importance. However, in most complex diseases, variant combinations in specific gene networks, rather than the presence of a particular single variant, predominates. In the case of complex diseases, disease status can be evaluated by considering the success level of a team of specific variants. We propose a high dimensional modelling based method to analyse all the variants in a gene network together, which we name “Computational Gene Network Analysis” (CoGNA).To evaluate our method, we selected two gene networks, mTOR and TGF- $\beta$ . For each pathway, we generated 400 control and 400 patient group samples. mTOR and TGF- $\beta$ pathways contain 31 and 93 genes of varying sizes, respectively. We produced Chaos Game Representation images for each gene sequence to obtain 2-D binary patterns. These patterns were arranged in succession, and a 3-D tensor structure was achieved for each gene network. Features for each data sample were acquired by exploiting Enhanced Multivariance Products Representation to 3-D data. Features were split as training and testing vectors. Training vectors were employed to train a Support Vector Machines classification model. We achieved more than $96\%$ and $99\%$ classification accuracies for mTOR and TGF- $\beta$ networks, respectively, using a limited amount of training samples.
- Open Access
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
A Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
Open AccessA Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel